Literature DB >> 29863242

Long non-coding RNA CCAT1 promotes the migration and invasion of prostate cancer PC-3 cells.

H Chen1, Y He, Y-S Hou, D-Q Chen, S-L He, Y-F Cao, X-M Wu.   

Abstract

OBJECTIVE: To investigate the effect of long non-coding RNA CCAT1 on the proliferation, migration, and invasion of prostate cancer PC-3 cells. PATIENTS AND METHODS: The expression of CCAT1 was detected by Real-time PCR. The effect of CCAT1 down-regulation on the proliferation of PC-3 cells was observed by MTT assay. The regulatory of CCAT1 low-expression on the migration ability of PC-3 cells was investigated by transwell assay. The influence of decreased CCAT1 on the invasion ability of PC-3 cells was detected by  Matrigel invasion assay.
RESULTS: Increased CCAT1 was significantly related to lymph node metastasis in prostate cancer. Low-expression of CCAT1 could suppress cell proliferation. Knockdown of CCAT1 inhibited the migration of PC-3 cells. Down-regulation of CCAT1 attenuated the invasion of PC-3 cells.
CONCLUSIONS: CCAT1 promoted the growth and the metastasis of prostate cancer. Our findings might provide a potential target for the diagnosis and treatment of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29863242     DOI: 10.26355/eurrev_201805_15055

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  7 in total

1.  A rare variant of African ancestry activates 8q24 lncRNA hub by modulating cancer associated enhancer.

Authors:  Kaivalya Walavalkar; Bharath Saravanan; Anurag Kumar Singh; Ranveer Singh Jayani; Ashwin Nair; Umer Farooq; Zubairul Islam; Deepanshu Soota; Rajat Mann; Padubidri V Shivaprasad; Matthew L Freedman; Radhakrishnan Sabarinathan; Christopher A Haiman; Dimple Notani
Journal:  Nat Commun       Date:  2020-07-17       Impact factor: 14.919

2.  Knockdown of lncRNA MNX1-AS1 suppresses cell proliferation, migration, and invasion in prostate cancer.

Authors:  Zongwu Li; Fangfei Wang; Shibao Zhang
Journal:  FEBS Open Bio       Date:  2019-04-13       Impact factor: 2.693

3.  CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling.

Authors:  Chunyong Han; Xuebiao Li; Qian Fan; Guangshu Liu; Jian Yin
Journal:  Aging (Albany NY)       Date:  2019-07-16       Impact factor: 5.682

4.  VIRMA-Dependent N6-Methyladenosine Modifications Regulate the Expression of Long Non-Coding RNAs CCAT1 and CCAT2 in Prostate Cancer.

Authors:  Daniela Barros-Silva; João Lobo; Catarina Guimarães-Teixeira; Isa Carneiro; Jorge Oliveira; Elena S Martens-Uzunova; Rui Henrique; Carmen Jerónimo
Journal:  Cancers (Basel)       Date:  2020-03-25       Impact factor: 6.639

Review 5.  Modern urology perspectives on prostate cancer biomarkers.

Authors:  Kamil Szeliski; Jan Adamowicz; Agata Gastecka; Tomasz Drewa; Marta Pokrywczyńska
Journal:  Cent European J Urol       Date:  2018-12-27

6.  Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1.

Authors:  Xiaohui Li; Xingtao Han; Pengtao Wei; Jinhui Yang; Jiantao Sun
Journal:  Cancer Biol Ther       Date:  2020-02-23       Impact factor: 4.742

7.  LncRNA CCAT1 promotes prostate cancer cells proliferation, migration, and invasion through regulation of miR-490-3p/FRAT1 axis.

Authors:  Xiaowei Cai; Yiheng Dai; Peng Gao; Guanyu Ren; Dingcai Cheng; Bo Wang; Yi Wang; Jiang Yu; Yiheng Du; Xizhi Wang; Boxin Xue
Journal:  Aging (Albany NY)       Date:  2021-07-28       Impact factor: 5.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.